The Senior Director of Marketing & Market Development will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s marketing function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands-on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life-changing science becomes real-world medicine.
The Senior Director of Marketing & Market Development will play an integral role in bringing our groundbreaking AAV gene therapies to patients with genetic cardiomyopathies. In this high-impact role, the incumbent will build Lexeo’s marketing function from the ground up, shaping brand strategy, market development, and launch readiness for first-in-class therapies poised to transform care in cardiac genetic diseases with high unmet need. You’ll combine strategic vision with hands-on execution, crafting compelling scientific narratives, driving disease awareness, and preparing providers, patients, and payers for a new era in gene therapy. This is a rare opportunity to define how life-changing science becomes real-world medicine.
Primary Responsibilities
Build, lead, and scale the marketing function; manage budget, resources, vendor/agency relationships, and KPIs tied to demand generation and launch readiness
Develop and execute integrated brand and marketing strategies for Lexeo’s cardiac pipeline(initially US-focused and future global expansion)
Shape and evolve Lexeo’s brand story as a leader in genetic cardiovascular medicine, partner with external communications (media, PR, social, thought leadership, IR)
Build deep customer segmentation and personas across key stakeholders: opinion leaders, cardiologists, genetic specialists, patient advocacy groups, and other members of multi-disciplinary care teams
Lead disease awareness and diagnosis-activation initiatives in partnership with Medical and Patient Affairs
Define evidence needs and value propositions for payer engagement, pricing, and provider strategies
Contribute to strategic planning and commercial prioritization across the portfolio
Develop messaging frameworks for HCPs, patients, and payers, emphasizing genetic causes, durability, and impact of therapies.
Expand Lexeo commercial infrastructure with an eye towards commercial launches, including data and analytics, field reporting, patient support and commercial intelligence
Serve as the commercial voice on cross-functional teams, ensuring alignment from early stage through launch
Collaborate with new and growing field teams, including market access, medical affairs, field reimbursement and sales
Required Skills & Qualifications
Bachelor’s in Life Sciences, Marketing, or Business required; MBA, PharmD, or PhD preferred.
10+ years in life sciences marketing (rare disease, gene therapy, advanced biologics), with both upstream (strategy, portfolio) and downstream (brand, digital) experience.
Experience in developing launch readiness for novel therapies (cell/gene therapies, biologics in rare/monogenic disease); experience in specialty/high-science areas is preferred
Strong scientific acumen; familiarity with AAV platforms, manufacturing, and regulatory pathways.
Deep competency in digital/omnichannel marketing: CRM, automation, SEO/SEM, analytics, content strategy.
Strong cross-functional collaboration skills and ability to influence senior leadership
Ability to translate complex science into compelling commercial narratives
About Lexeo
Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment.
These cookies are necessary for the website to function and cannot be turned off in our systems. You can set your browser to block these cookies, but then some parts of the website might not work.
Security
User experience
Target group oriented cookies
These cookies are set through our website by our advertising partners. They may be used by these companies to profile your interests and show you relevant advertising elsewhere.
Google Analytics
Google Ads
We use cookies
🍪
Our website uses cookies and similar technologies to personalize content, optimize the user experience and to indvidualize and evaluate advertising. By clicking Okay or activating an option in the cookie settings, you agree to this.
The best remote jobs via email
Join 5'000+ people getting weekly alerts with remote jobs!